Real Estate - Services
Compare Stocks
4 / 10Stock Comparison
TCI vs WELL vs NHI vs VTR
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
TCI vs WELL vs NHI vs VTR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $317M | $149.25B | $3.64B | $41.15B |
| Revenue (TTM) | $49M | $11.63B | $403M | $6.13B |
| Net Income (TTM) | $9M | $1.43B | $148M | $260M |
| Gross Margin | -38.7% | 39.1% | 61.3% | -4.3% |
| Operating Margin | -11.6% | 4.4% | 48.5% | 13.4% |
| Forward P/E | 22.9x | 78.4x | 22.2x | 118.0x |
| Total Debt | $211M | $21.38B | $1.16B | $13.22B |
| Cash & Equiv. | $14M | $5.03B | $20M | $741M |
TCI vs WELL vs NHI vs VTR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Transcontinental Re… (TCI) | 100 | 181.4 | +81.4% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
| Ventas, Inc. (VTR) | 100 | 247.6 | +147.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TCI vs WELL vs NHI vs VTR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TCI lags the leaders in this set but could rank higher in a more targeted comparison.
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs TCI's 324.2%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs TCI's 9.6%
NHI is the #2 pick in this set and the best alternative if value and quality is your priority.
- Lower P/E (22.2x vs 118.0x)
- 36.8% margin vs VTR's 4.2%
- 5.4% ROA vs TCI's 0.8%, ROIC 5.6% vs -0.5%
VTR is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs TCI's 0.75
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs TCI's 9.6% | |
| Value | Lower P/E (22.2x vs 118.0x) | |
| Quality / Margins | 36.8% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs TCI's 0.75 | |
| Dividends | 1.3% yield, 2-year raise streak, vs NHI's 4.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.7% vs NHI's +2.8% | |
| Efficiency (ROA) | 5.4% ROA vs TCI's 0.8%, ROIC 5.6% vs -0.5% |
TCI vs WELL vs NHI vs VTR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TCI vs WELL vs NHI vs VTR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 1 of 6 categories
WELL leads 1 • TCI leads 0 • VTR leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 235.5x TCI's $49M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $11.6B | $403M | $6.1B |
| EBITDAEarnings before interest/tax | $5M | $2.8B | $282M | $2.3B |
| Net IncomeAfter-tax profit | $9M | $1.4B | $148M | $260M |
| Free Cash FlowCash after capex | -$51M | $2.5B | $226M | $1.4B |
| Gross MarginGross profit ÷ Revenue | -38.7% | +39.1% | +61.3% | -4.3% |
| Operating MarginEBIT ÷ Revenue | -11.6% | +4.4% | +48.5% | +13.4% |
| Net MarginNet income ÷ Revenue | +18.9% | +12.3% | +36.8% | +4.2% |
| FCF MarginFCF ÷ Revenue | -104.2% | +21.9% | +56.1% | +22.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.8% | +40.3% | +29.7% | +22.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -96.2% | +22.5% | +10.8% | 0.0% |
Valuation Metrics
Evenly matched — TCI and NHI each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 22.9x trailing earnings, TCI trades at a 86% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, NHI's 17.2x EV/EBITDA is more attractive than TCI's 82.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $317M | $149.2B | $3.6B | $41.1B |
| Enterprise ValueMkt cap + debt − cash | $513M | $165.6B | $4.8B | $53.6B |
| Trailing P/EPrice ÷ TTM EPS | 22.91x | 153.25x | 24.85x | 160.26x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 22.17x | 118.01x |
| PEG RatioP/E ÷ EPS growth rate | 1.45x | — | — | — |
| EV / EBITDAEnterprise value multiple | 82.37x | 66.40x | 17.16x | 24.31x |
| Price / SalesMarket cap ÷ Revenue | 6.45x | 13.99x | 9.61x | 7.05x |
| Price / BookPrice ÷ Book value/share | 0.37x | 3.35x | 2.29x | 3.18x |
| Price / FCFMarket cap ÷ FCF | — | 52.41x | 16.52x | 31.25x |
Profitability & Efficiency
Evenly matched — TCI and NHI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $1 for TCI. TCI carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs TCI's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.1% | +3.5% | +9.8% | +2.1% |
| ROA (TTM)Return on assets | +0.8% | +2.3% | +5.4% | +1.0% |
| ROICReturn on invested capital | -0.5% | +0.5% | +5.6% | +2.5% |
| ROCEReturn on capital employed | -0.6% | +0.6% | +8.0% | +3.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.24x | 0.49x | 0.76x | 1.05x |
| Net DebtTotal debt minus cash | $197M | $16.3B | $1.1B | $12.5B |
| Cash & Equiv.Liquid assets | $14M | $5.0B | $20M | $741M |
| Total DebtShort + long-term debt | $211M | $21.4B | $1.2B | $13.2B |
| Interest CoverageEBIT ÷ Interest expense | 4.22x | 0.26x | 3.45x | 1.40x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $13,097 for NHI. Over the past 12 months, WELL leads with a +42.7% total return vs NHI's +2.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs TCI's 1.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -37.8% | +14.3% | -1.1% | +12.6% |
| 1-Year ReturnPast 12 months | +18.5% | +42.7% | +2.8% | +33.9% |
| 3-Year ReturnCumulative with dividends | +4.7% | +189.5% | +73.5% | +94.2% |
| 5-Year ReturnCumulative with dividends | +72.8% | +202.3% | +31.0% | +74.8% |
| 10-Year ReturnCumulative with dividends | +324.2% | +223.1% | +58.9% | +65.0% |
| CAGR (3Y)Annualised 3-year return | +1.5% | +42.5% | +20.2% | +24.8% |
Risk & Volatility
Evenly matched — NHI and VTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than TCI's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs TCI's 61.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.13x | -0.08x | 0.01x |
| 52-Week HighHighest price in past year | $59.65 | $219.59 | $90.94 | $88.50 |
| 52-Week LowLowest price in past year | $29.26 | $142.65 | $68.80 | $61.76 |
| % of 52W HighCurrent price vs 52-week peak | +61.4% | +97.0% | +82.5% | +97.8% |
| RSI (14)Momentum oscillator 0–100 | 46.4 | 60.2 | 28.0 | 56.2 |
| Avg Volume (50D)Average daily shares traded | 7K | 2.6M | 332K | 3.4M |
Analyst Outlook
Evenly matched — WELL and NHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", NHI as "Hold", VTR as "Buy". Consensus price targets imply 13.8% upside for NHI (target: $85) vs 4.9% for VTR (target: $91). For income investors, NHI offers the higher dividend yield at 4.80% vs WELL's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $226.50 | $85.40 | $90.80 |
| # AnalystsCovering analysts | — | 34 | 18 | 32 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +4.8% | +2.1% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | $2.76 | $3.61 | $1.86 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | 0.0% | 0.0% | 0.0% |
NHI leads in 1 of 6 categories (Income & Cash Flow). WELL leads in 1 (Total Returns). 4 tied.
TCI vs WELL vs NHI vs VTR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TCI or WELL or NHI or VTR a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 9. 6% for Transcontinental Realty Investors, Inc. (TCI). Transcontinental Realty Investors, Inc. (TCI) offers the better valuation at 22. 9x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TCI or WELL or NHI or VTR?
On trailing P/E, Transcontinental Realty Investors, Inc.
(TCI) is the cheapest at 22. 9x versus Ventas, Inc. at 160. 3x. On forward P/E, National Health Investors, Inc. is actually cheaper at 22. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TCI or WELL or NHI or VTR?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to +31. 0% for National Health Investors, Inc. (NHI). Over 10 years, the gap is even starker: TCI returned +324. 2% versus NHI's +58. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TCI or WELL or NHI or VTR?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Transcontinental Realty Investors, Inc. 's 0. 75β — meaning TCI is approximately -990% more volatile than NHI relative to the S&P 500. On balance sheet safety, Transcontinental Realty Investors, Inc. (TCI) carries a lower debt/equity ratio of 24% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TCI or WELL or NHI or VTR?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 9. 6% for Transcontinental Realty Investors, Inc. (TCI). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TCI or WELL or NHI or VTR?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -12. 9% for TCI. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TCI or WELL or NHI or VTR more undervalued right now?
On forward earnings alone, National Health Investors, Inc.
(NHI) trades at 22. 2x forward P/E versus 118. 0x for Ventas, Inc. — 95. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — TCI or WELL or NHI or VTR?
In this comparison, NHI (4.
8% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. TCI does not pay a meaningful dividend and should not be held primarily for income.
09Is TCI or WELL or NHI or VTR better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, TCI: +324. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TCI and WELL and NHI and VTR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TCI is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; NHI is a small-cap income-oriented stock; VTR is a mid-cap high-growth stock. WELL, NHI, VTR pay a dividend while TCI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.